Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sendhil SR"'
Autor:
Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, Sundar M, Hagopian E, Stempniewicz N, Duh MS, Poston S
Publikováno v:
Psoriasis: Targets and Therapy, Vol Volume 14, Pp 63-78 (2024)
David Singer,1 Philippe Thompson-Leduc,2 Siyu Ma,1,3 Deepshekhar Gupta,4 Wendy Y Cheng,5 Selvam R Sendhil,6 Manasvi Sundar,6 Ella Hagopian,5 Nikita Stempniewicz,1 Mei Sheng Duh,5 Sara Poston1 1GSK, US Health Economics and Outcomes Research, Philadelp
Externí odkaz:
https://doaj.org/article/97b00cf25c584e52bb69f44b305d059d
Autor:
Marrett E; Health Economics and Outcomes Research, Daiichi Sankyo, Inc., 211 Mt Airy Rd, Basking Ridge, NJ, 07920, USA. emarrett@dsi.com., Kwong WJ; Health Economics and Outcomes Research, Daiichi Sankyo, Inc., 211 Mt Airy Rd, Basking Ridge, NJ, 07920, USA., Xie J; Analysis Group, Los Angeles, CA, USA., Manceur AM; Analysis Group, Montreal, QC, Canada., Sendhil SR; Analysis Group, Los Angeles, CA, USA., Wu E; Analysis Group, Boston, MA, USA., Ionescu-Ittu R; Analysis Group, Montreal, QC, Canada., Subramanian J; Inova Schar Cancer Institute, Fairfax, VA, USA.
Publikováno v:
Drugs - real world outcomes [Drugs Real World Outcomes] 2023 Dec; Vol. 10 (4), pp. 531-544. Date of Electronic Publication: 2023 Sep 02.
Autor:
Singer D; GSK, US Health Outcomes and Epidemiology, Vaccines, FMC Tower Suite 1700, 2929 Walnut Street, Philadelphia, PA19104, USA., Thompson-Leduc P; Analysis Group, Inc., Montreal, QC, Canada., Ma S; GSK, US Health Outcomes and Epidemiology, Vaccines, FMC Tower Suite 1700, 2929 Walnut Street, Philadelphia, PA19104, USA.; Tufts Medical Center, Boston, MA, USA., Gupta D; Analysis Group, Inc., Menlo Park, CA, USA., Cheng WY; Analysis Group, Inc., Boston, MA, USA., Sendhil SR; Analysis Group, Inc., Los Angeles, CA, USA., Sundar M; Analysis Group, Inc., Los Angeles, CA, USA., Hagopian E; Analysis Group, Inc., Boston, MA, USA., Stempniewicz N; GSK, US Health Outcomes and Epidemiology, Vaccines, FMC Tower Suite 1700, 2929 Walnut Street, Philadelphia, PA19104, USA. nikita.x.stempniewicz@gsk.com., Duh MS; Analysis Group, Inc., Boston, MA, USA., Poston S; GSK, US Health Outcomes and Epidemiology, Vaccines, FMC Tower Suite 1700, 2929 Walnut Street, Philadelphia, PA19104, USA.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Nov; Vol. 13 (11), pp. 2649-2668. Date of Electronic Publication: 2023 Sep 22.
Autor:
McGregor B; Dana-Farber Cancer Institute, Boston, MA, USA., Geynisman DM; Fox Chase Cancer Center, Philadelphia, PA, USA., Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile., Porta C; University of Bari 'A. Moro,' and Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy., Suarez C; Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d´Hebron, Vall d´Hebron Barcelona Hospital Campus, Barcelona, Spain., Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Del Tejo V; Bristol Myers Squibb, Princeton, NJ, USA., Du EX; Analysis Group, Inc., Los Angeles, CA, USA., Yang X; Analysis Group, Inc., Los Angeles, CA, USA., Sendhil SR; Analysis Group, Inc., Los Angeles, CA, USA., Betts KA; Analysis Group, Inc., Los Angeles, CA, USA., Huo S; Bristol Myers Squibb, Princeton, NJ, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Jan 18; Vol. 28 (1), pp. 72-79.
Autor:
Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany. andreas.reiter@medma.uni-heidelberg.de., Gotlib J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA., Álvarez-Twose I; Institute of Mastocytosis Studies of Castilla La Mancha (CLMast)-Spanish Reference Center (CSUR) for Mastocytosis and CIBERONC, Virgen del Valle Hospital, Toledo, Spain., Radia DH; Guy's and St Thomas' NHS Foundation Trust of Guy's Hospital, London, UK., Lübke J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Bobbili PJ; Analysis Group, Inc., Boston, MA, USA., Wang A; Analysis Group, Inc., Boston, MA, USA., Norregaard C; Blueprint Medicines Corporation, Cambridge, MA, USA., Dimitrijevic S; Blueprint Medicines Corporation, Zug, Switzerland., Sullivan E; Blueprint Medicines Corporation, Cambridge, MA, USA., Louie-Gao M; Blueprint Medicines Corporation, Cambridge, MA, USA., Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Perkins C; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA., Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Sriskandarajah P; Guy's and St Thomas' NHS Foundation Trust of Guy's Hospital, London, UK., Chin A; Analysis Group, Inc., Boston, MA, USA., Sendhil SR; Analysis Group, Inc., Boston, MA, USA., Duh MS; Analysis Group, Inc., Boston, MA, USA., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Leukemia [Leukemia] 2022 Aug; Vol. 36 (8), pp. 2108-2120. Date of Electronic Publication: 2022 Jul 05.
Autor:
Thornburg CD; Division of Pediatric Hematology/Oncology, Rady Children's Hospital-San Diego, San Diego, CA, and Department of Pediatrics, UC San Diego School of Medicine, La Jolla, CA., Adamski K; Analysis Group, Inc., Los Angeles, CA., Cook K; Analysis Group, Inc., Menlo Park, CA., Vembusubramanian M; Analysis Group, Inc., Los Angeles, CA., Sendhil SR; Analysis Group, Inc., Los Angeles, CA., Hinds D; BioMarin Pharmaceutical Inc., Novato, CA., Chen E; BioMarin Pharmaceutical Inc., Novato, CA., Sammon J; BioMarin Pharmaceutical Inc., Novato, CA., Solari P; BioMarin Pharmaceutical Inc., Novato, CA., Garrison LP Jr; CHOICE Institute, Department of Pharmacy, University of Washington, Seattle., Croteau SE; Division of Hematology-Oncology, Boston Children's Hospital/Harvard Medical School, Boston, MA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Apr; Vol. 28 (4), pp. 449-460. Date of Electronic Publication: 2021 Dec 27.
Autor:
Geynisman DM; Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Du EX; Analysis Group, Inc., 333 South Hope Street, Los Angeles, CA 90071, USA., Yang X; Analysis Group, Inc., 333 South Hope Street, Los Angeles, CA 90071, USA., Sendhil SR; Analysis Group, Inc., 333 South Hope Street, Los Angeles, CA 90071, USA., Tejo VD; Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, NJ 08540, USA., Betts KA; Analysis Group, Inc., 333 South Hope Street, Los Angeles, CA 90071, USA., Huo S; Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, NJ 08540, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Mar; Vol. 18 (10), pp. 1219-1234. Date of Electronic Publication: 2021 Dec 23.